Limits...
Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study.

Hibbitts S, Jones J, Powell N, Dallimore N, McRea J, Beer H, Tristram A, Fielder H, Fiander AN - Br. J. Cancer (2008)

Bottom Line: Here, 66% of all HR HPV cases were in women aged 30 years of age or less and SDS had no significant effect on HPV status.Overall, 46% of HR HPV cases were positive for the two HR types targeted by the prophylactic vaccines (HPV 16 and HPV 18).The data presented represents the largest type-specific investigation of HPV prevalence in an unselected UK population.

View Article: PubMed Central - PubMed

Affiliation: Department of Obstetrics & Gynaecology, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK. hibbittssj@cf.ac.uk

ABSTRACT
In this cross-sectional population-based study we determine human papillomavirus (HPV) prevalence in South Wales to provide comprehensive baseline data for future assessment of the impact of prophylactic HPV vaccination and to help inform future screening strategies. Liquid-based cytology samples from women attending routine cervical screening were collected (n=10 000: mean age 38 years, 93% cytology negative, and 64.8% from the 50% least deprived LSOA according to social deprivation score (SDS)). High-Risk (HR) and Low-Risk HPV screening was performed using HPV PCR-EIA with genotyping of HR positives and data correlated with age, SDS and cytology. Overall HPV prevalence was 13.5% (9.3% age standardised) and the most frequent HR types were HPV 16, 31, 18 and 58. In HR HPV-positive cases 42.4% had a single HR type and they were predominant in women with severe cytological abnormalities. Here, 66% of all HR HPV cases were in women aged 30 years of age or less and SDS had no significant effect on HPV status. HPV prevalence increased significantly with degree of dyskaryosis from 7% in cytology negative samples to 80% in samples with severe cytological abnormalities (P-value <0.0001). Overall, 46% of HR HPV cases were positive for the two HR types targeted by the prophylactic vaccines (HPV 16 and HPV 18). The data presented represents the largest type-specific investigation of HPV prevalence in an unselected UK population.

Show MeSH

Related in: MedlinePlus

HPV Prevalence Distribution with Social Deprivation Score. The total number of HR HPV, single HR and multiple HR cases in each LSOA rank was calculated as a percentage of the total number of women in the study population (9079) classified as 10% most deprived LSOA (n=866), 10–20% most deprived LSOA (n=512), 20–30% most deprived LSOA (n=673), 30–50% most deprived LSOA (n=1144) and 50% least deprived LSOA in Wales (n=5884).
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2600697&req=5

fig4: HPV Prevalence Distribution with Social Deprivation Score. The total number of HR HPV, single HR and multiple HR cases in each LSOA rank was calculated as a percentage of the total number of women in the study population (9079) classified as 10% most deprived LSOA (n=866), 10–20% most deprived LSOA (n=512), 20–30% most deprived LSOA (n=673), 30–50% most deprived LSOA (n=1144) and 50% least deprived LSOA in Wales (n=5884).

Mentions: Most of the women in the study were from the 50% least deprived LSOA (64.8%) and the lowest HR HPV prevalence was detected in the 50% least deprived LSOA in Wales (10.5%) with the highest in the 10% most deprived LSOA (13.3%) according to SDS. However, HR HPV cases were not significantly more prevalent in any one rank (Figure 4).


Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study.

Hibbitts S, Jones J, Powell N, Dallimore N, McRea J, Beer H, Tristram A, Fielder H, Fiander AN - Br. J. Cancer (2008)

HPV Prevalence Distribution with Social Deprivation Score. The total number of HR HPV, single HR and multiple HR cases in each LSOA rank was calculated as a percentage of the total number of women in the study population (9079) classified as 10% most deprived LSOA (n=866), 10–20% most deprived LSOA (n=512), 20–30% most deprived LSOA (n=673), 30–50% most deprived LSOA (n=1144) and 50% least deprived LSOA in Wales (n=5884).
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2600697&req=5

fig4: HPV Prevalence Distribution with Social Deprivation Score. The total number of HR HPV, single HR and multiple HR cases in each LSOA rank was calculated as a percentage of the total number of women in the study population (9079) classified as 10% most deprived LSOA (n=866), 10–20% most deprived LSOA (n=512), 20–30% most deprived LSOA (n=673), 30–50% most deprived LSOA (n=1144) and 50% least deprived LSOA in Wales (n=5884).
Mentions: Most of the women in the study were from the 50% least deprived LSOA (64.8%) and the lowest HR HPV prevalence was detected in the 50% least deprived LSOA in Wales (10.5%) with the highest in the 10% most deprived LSOA (13.3%) according to SDS. However, HR HPV cases were not significantly more prevalent in any one rank (Figure 4).

Bottom Line: Here, 66% of all HR HPV cases were in women aged 30 years of age or less and SDS had no significant effect on HPV status.Overall, 46% of HR HPV cases were positive for the two HR types targeted by the prophylactic vaccines (HPV 16 and HPV 18).The data presented represents the largest type-specific investigation of HPV prevalence in an unselected UK population.

View Article: PubMed Central - PubMed

Affiliation: Department of Obstetrics & Gynaecology, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK. hibbittssj@cf.ac.uk

ABSTRACT
In this cross-sectional population-based study we determine human papillomavirus (HPV) prevalence in South Wales to provide comprehensive baseline data for future assessment of the impact of prophylactic HPV vaccination and to help inform future screening strategies. Liquid-based cytology samples from women attending routine cervical screening were collected (n=10 000: mean age 38 years, 93% cytology negative, and 64.8% from the 50% least deprived LSOA according to social deprivation score (SDS)). High-Risk (HR) and Low-Risk HPV screening was performed using HPV PCR-EIA with genotyping of HR positives and data correlated with age, SDS and cytology. Overall HPV prevalence was 13.5% (9.3% age standardised) and the most frequent HR types were HPV 16, 31, 18 and 58. In HR HPV-positive cases 42.4% had a single HR type and they were predominant in women with severe cytological abnormalities. Here, 66% of all HR HPV cases were in women aged 30 years of age or less and SDS had no significant effect on HPV status. HPV prevalence increased significantly with degree of dyskaryosis from 7% in cytology negative samples to 80% in samples with severe cytological abnormalities (P-value <0.0001). Overall, 46% of HR HPV cases were positive for the two HR types targeted by the prophylactic vaccines (HPV 16 and HPV 18). The data presented represents the largest type-specific investigation of HPV prevalence in an unselected UK population.

Show MeSH
Related in: MedlinePlus